LiveOne_Logo_400x400 (3).png
LiveOne (Nasdaq: LVO) Anticipates Certain Record Q4 and FY24 Results
April 22, 2024 08:54 ET | LiveOne, Inc.
- FY24: Expects $118.5M revenue, $14.4M Adjusted EBITDA* (excluding $3.5M CPS division loss) - Q4 FY24: Expects $30.3M revenue, $4.3M Adjusted EBITDA* (excluding $1.6M CPS loss) - LVO...
Cidara.png
Cidara Therapeutics Announces Reverse Stock Split
April 22, 2024 08:49 ET | Cidara Therapeutics, Inc.
SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate...
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL DISTRIBUTIONS - Ordinary Shares
April 22, 2024 08:46 ET | Dimensional Fund Advisors Ltd
FORM 8.3 ** AMENDMENT** This form replaces the filing reported on 22 April 2024 11:56 am. Amendments were made to section 2(a) and 3(a)" PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA...
AECON_Red.jpg
Aecon releases 2023 Sustainability Report highlighting its progress and role in Advancing the Energy Transition
April 22, 2024 08:46 ET | Aecon Group Inc.
TORONTO, April 22, 2024 (GLOBE NEWSWIRE) -- Aecon Group Inc. (TSX: ARE) (“Aecon” or the “Company”) today released its 2023 Sustainability Report highlighting its progress and role in Advancing the...
Logo_full_color_Symbol_Blueslash.png
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
April 22, 2024 08:45 ET | Cannabix Technologies Inc.
VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana...
Picture2.jpg
ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
April 22, 2024 08:45 ET | ASLAN PHARMACEUTICALS LIMITED
ASLAN Pharmaceuticals announces positive interim results from phase 2 study of eblasakimab in dupilumab-experienced atopic dermatitis patients
Alliance Trust PLC - Net Asset Value
April 22, 2024 08:44 ET | Alliance Trust Plc
ALLIANCE TRUST PLC                 At the close of business Friday 19 April 2024: The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income,...
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
April 22, 2024 08:42 ET | Dimensional Fund Advisors Ltd
FORM 8.3 ** AMENDMENT** This form replaces the filing reported on 22 April 2024 11:53am. Amendments were made to section 2(a) and 3(a)" PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA...
Schneider Electric highlights the importance of software, automation and electrification in accelerating industrial competitiveness
April 22, 2024 08:40 ET | Schneider Electric SE
Schneider Electric outlines how software-defined automation is driving industrial growth at Hannover MesseAlongside AVEVA, company unveils latest innovations aimed at boosting industrial productivity,...
Dr. Bhavin Patel Joi
Dr. Bhavin Patel Joins DHAT in Bedford
April 22, 2024 08:40 ET | GI Alliance
Bedford, TX, April 22, 2024 (GLOBE NEWSWIRE) -- Digestive Health Associates of Texas is proud to welcome the addition of Dr. Bhavin Patel, a physician passionate about treating all gastrointestinal...